{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:20:10Z","timestamp":1791192010353,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1124\/mol.106.028233","type":"journal-article","created":{"date-parts":[[2006,11,17]],"date-time":"2006-11-17T01:45:33Z","timestamp":1163727933000},"page":"619-627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":254,"title":["Functional Involvement of Multidrug Resistance-Associated Protein 4 (MRP4\/ABCC4) in the Renal Elimination of the Antiviral Drugs Adefovir and Tenofovir"],"prefix":"10.1016","volume":"71","author":[{"given":"Tomoki","family":"Imaoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kusuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Schuetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.106.028233_REF1","doi-asserted-by":"crossref","first-page":"22250","DOI":"10.1074\/jbc.M314111200","article-title":"Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice","volume":"279","author":"Assem","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.106.028233_REF2","doi-asserted-by":"crossref","first-page":"8686","DOI":"10.1016\/S0021-9258(18)31500-X","article-title":"5-Phosphoribosyl 1-pyrophosphate synthetase converts the acyclic nucleoside phosphonates 9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 9-(2-phosphonylmethoxyethyl)adenine directly to their antivirally active diphosphate derivatives","volume":"266","author":"Balzarini","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.106.028233_REF3","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1073\/pnas.88.4.1499","article-title":"Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound","volume":"88","author":"Balzarini","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.106.028233_REF4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1081\/NCN-100002341","article-title":"Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs","volume":"20","author":"Cihlar","year":"2001","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1124\/mol.106.028233_REF5","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0026-895X(24)23084-4","article-title":"The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1","volume":"56","author":"Cihlar","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.106.028233_REF6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00003088-199936020-00004","article-title":"Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir","volume":"36","author":"Cundy","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/mol.106.028233_REF7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.16.4.569-596.2003","article-title":"Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections","volume":"16","author":"De Clercq","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1124\/mol.106.028233_REF8","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1081\/NCN-100002496","article-title":"Metabolism of GS-7340, a novel phenyl monophosphoramidate intracellular prodrug of PMPA, in blood","volume":"20","author":"Eisenberg","year":"2001","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1124\/mol.106.028233_REF9","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1086\/428840","article-title":"Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment","volume":"40","author":"Gallant","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1124\/mol.106.028233_REF10","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1023\/B:PHAM.0000026422.06207.33","article-title":"Characterization of the cellular localization, expression level, and function of SNP variants of MRP2\/ABCC2","volume":"21","author":"Hirouchi","year":"2004","journal-title":"Pharm Res (NY)"},{"key":"10.1124\/mol.106.028233_REF11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1681\/ASN.V113383","article-title":"Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1","volume":"11","author":"Ho","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/mol.106.028233_REF12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0026-895X(25)08828-5","article-title":"Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine","volume":"41","author":"Ho","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.106.028233_REF13","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1046\/j.1523-1755.2000.00251.x","article-title":"Cellular and molecular aspects of drug transport in the kidney","volume":"58","author":"Inui","year":"2000","journal-title":"Kidney Int"},{"key":"10.1124\/mol.106.028233_REF14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/01.aids.0000162333.35686.4c","article-title":"Renal tubular transporters and antiviral drugs: an update","volume":"19","author":"Izzedine","year":"2005","journal-title":"AIDS"},{"key":"10.1124\/mol.106.028233_REF15","doi-asserted-by":"crossref","first-page":"15649","DOI":"10.1073\/pnas.202607599","article-title":"The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria","volume":"99","author":"Jonker","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.106.028233_REF16","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1001\/jama.282.24.2305","article-title":"Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial","volume":"282","author":"Kahn","year":"1999","journal-title":"J Am Med Assoc"},{"key":"10.1124\/mol.106.028233_REF17","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00424-003-1089-9","article-title":"The SLC22 drug transporter family","volume":"447","author":"Koepsell","year":"2004","journal-title":"Pflueg Arch Eur J Physiol"},{"key":"10.1124\/mol.106.028233_REF18","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1023\/B:PHAM.0000045245.21637.d4","article-title":"Functional analysis of SNPs variants of BCRP\/ABCG2","volume":"21","author":"Kondo","year":"2004","journal-title":"Pharm Res (NY)"},{"key":"10.1124\/mol.106.028233_REF19","first-page":"3537","article-title":"Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines","volume":"57","author":"Kool","year":"1997","journal-title":"Cancer Res"},{"key":"10.1124\/mol.106.028233_REF20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-126-4-199702150-00001","article-title":"Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial","volume":"126","author":"Lalezari","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1124\/mol.106.028233_REF21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.pharmtox.44.101802.121856","article-title":"Transporters and renal drug elimination","volume":"44","author":"Lee","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/mol.106.028233_REF22","doi-asserted-by":"crossref","first-page":"7612","DOI":"10.1128\/MCB.24.17.7612-7621.2004","article-title":"Mrp4 confers resistance to topotecan and protects the brain from chemotherapy","volume":"24","author":"Leggas","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.106.028233_REF23","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1124\/dmd.105.003780","article-title":"Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (Mrp) family in mice","volume":"33","author":"Maher","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.106.028233_REF24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0022-3565(24)38862-7","article-title":"Nonsteroidal anti-inflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1","volume":"295","author":"Mulato","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.106.028233_REF25","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0090-9556(25)08788-4","article-title":"Pharmacokinetics in mice of the anti-retrovirus agent 9-(2-phosphonylmethoxyethyl)adenine","volume":"20","author":"Naesens","year":"1992","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.106.028233_REF26","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2133\/dmpk.20.452","article-title":"Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies","volume":"20","author":"Nishimura","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/mol.106.028233_REF27","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1124\/mol.63.5.1094","article-title":"Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5","volume":"63","author":"Reid","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.106.028233_REF28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2003.50331","article-title":"Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane","volume":"38","author":"Rius","year":"2003","journal-title":"Hepatology"},{"key":"10.1124\/mol.106.028233_REF29","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1128\/AAC.39.10.2304","article-title":"Metabolic pathways for activation of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine in human lymphoid cells","volume":"39","author":"Robbins","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.106.028233_REF30","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1086\/503566","article-title":"HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy","volume":"42","author":"Roling","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1124\/mol.106.028233_REF31","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/AAC.47.9.2933-2937.2003","article-title":"Aerosolized cidofovir is retained in the respiratory tract and protects mice against intranasal cowpox virus challenge","volume":"47","author":"Roy","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.106.028233_REF32","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1681\/ASN.V881213","article-title":"Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules","volume":"8","author":"Schaub","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/mol.106.028233_REF33","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/12487","article-title":"MRP4: a previously unidentified factor in resistance to nucleoside-based antiviral drugs","volume":"5","author":"Schuetz","year":"1999","journal-title":"Nat Med"},{"key":"10.1124\/mol.106.028233_REF34","first-page":"F251","article-title":"Molecular physiology of renal organic anion transporters","volume":"290","author":"Sekine","year":"2006","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.106.028233_REF35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.taap.2004.10.016","article-title":"Organic anion transporter (Slc22a) family members as mediators of toxicity","volume":"204","author":"Sweet","year":"2005","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/mol.106.028233_REF36","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1681\/ASN.V133595","article-title":"The MRP4\/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP","volume":"13","author":"van Aubel","year":"2002","journal-title":"JAm Soc Nephrol"},{"key":"10.1124\/mol.106.028233_REF37","first-page":"F327","article-title":"Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites","volume":"288","author":"Van Aubel","year":"2005","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.106.028233_REF38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.taap.2004.10.021","article-title":"Role of organic cation transporters in the renal handling of therapeutic agents and xenobiotics","volume":"204","author":"Wright","year":"2005","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/mol.106.028233_REF39","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/bj20021886","article-title":"Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4)","volume":"371","author":"Zelcer","year":"2003","journal-title":"Biochem J"},{"key":"10.1124\/mol.106.028233_REF40","first-page":"G923","article-title":"Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter {alpha}\/{beta} in the adaptive response to bile acids","volume":"290","author":"Zollner","year":"2006","journal-title":"Am J Physiol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24043463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24043463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.106.028233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:46:23Z","timestamp":1739965583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24043463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0026895X24043463"],"URL":"https:\/\/doi.org\/10.1124\/mol.106.028233","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional Involvement of Multidrug Resistance-Associated Protein 4 (MRP4\/ABCC4) in the Renal Elimination of the Antiviral Drugs Adefovir and Tenofovir","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.106.028233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}